Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $44.81M in the quarter ending March 31, 2026, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $227.18M, down -2.38% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%.

• Revenue (ttm): $227.18M
• Revenue Growth: -2.38%
• P/S Ratio: 1.70
• Revenue / Employee: $1,269,112
• Employees: 179
• Market Cap: 381.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	228.37M	-2.10M	-0.91%
Dec 31, 2024	230.47M	-5.17M	-2.19%
Dec 31, 2023	235.64M	7.61M	3.34%
Dec 31, 2022	228.03M	-25.12M	-9.92%
Dec 31, 2021	253.16M	28.05M	12.46%
Dec 31, 2020	225.11M	-47.15M	-17.32%
Dec 31, 2019	272.26M	21.27M	8.47%
Dec 31, 2018	250.99M	223.31M	806.60%
Dec 31, 2017	27.69M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error